Quantification of viable tumor microvascular characteristics by multispectral analysis
Authors:
Open Access
- 17 April 2008
- journal article
- research article
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 60 (1) , 64-72
Abstract
Tumor heterogeneity complicates the quantification of tumor microvascular characteristics assessed by dynamic contrast‐enhanced MRI (DCE‐MRI). To address this issue a novel approach was developed that combines DCE‐MRI with diffusion‐based multispectral (MS) analysis to quantify the microvascular characteristics of specific tumor tissue populations. Diffusion‐based MS segmentation (feature space: apparent diffusion coefficient, T2 and proton density) was performed to identify tumor tissue populations and the DCE‐MRI characteristics were determined for each tissue class. The ability of this MS DCE‐MRI technique to detect microvascular changes due to treatment with an antibody (G6‐31) to vascular endothelial growth factor‐A (VEGF) was evaluated in a tumor xenograft mouse model. Anti‐VEGF treatment resulted in a significant reduction in Ktrans for the MS viable tumor tissue class (−0.0034 ± 0.0022 min−1, P < 0.01) at 24 hr posttreatment that differ significantly from the change observed in the control group (0.0002 ± 0.0025 min−1). Viable tumor Ktrans for the anti‐VEGF group was also reduced 62% relative to the pretreatment values (P < 0.01). Necrotic tissue classes were found to add only noise to DCE‐MRI estimates. This approach provides a means to measure physiological parameters within the viable tumor and address the issue of tumor heterogeneity that complicates DCE‐MRI analysis. Magn Reson Med, 2008.Keywords
This publication has 38 references indexed in Scilit:
- Vascular Endothelial Growth Factor Signaling Pathway as an Emerging Target in Hematologic MalignanciesThe Oncologist, 2001
- Clinical Implications of Circulating Angiogenic Factors in Cancer PatientsJournal of Clinical Oncology, 2001
- Prognostic value of vascular endothelial growth factor expression in colorectal cancer patientsEuropean Journal of Cancer, 2000
- Vascular endothelial growth factor is essential for corpus luteum angiogenesisNature Medicine, 1998
- Vascular endothelial growth factor increases hydraulic conductivity of isolated perfused microvesselsAmerican Journal of Physiology-Heart and Circulatory Physiology, 1996
- Vascular Permeability Factor, an Endothelial Cell Mitogen Related to PDGFScience, 1989
- Vascular Endothelial Growth Factor Is a Secreted Angiogenic MitogenScience, 1989
- Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cellsBiochemical and Biophysical Research Communications, 1989
- Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites FluidScience, 1983
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971